Jayadeep Patra

Author PubWeight™ 116.12‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 50.94
2 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009 16.12
3 The relation between different dimensions of alcohol consumption and burden of disease: an overview. Addiction 2010 5.14
4 Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care 2009 3.03
5 Hours and days of sale and density of alcohol outlets: impacts on alcohol consumption and damage: a systematic review. Alcohol Alcohol 2009 2.71
6 The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009 2.39
7 Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010 2.37
8 Changes in illicit opioid use across Canada. CMAJ 2006 2.20
9 Alcohol-attributable mortality and potential years of life lost in Canada 2001: implications for prevention and policy. Addiction 2006 2.01
10 Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction 2011 1.93
11 Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol 2007 1.89
12 Volume of alcohol consumption, patterns of drinking and burden of disease in the European region 2002. Addiction 2006 1.79
13 Alcohol and hypertension: gender differences in dose-response relationships determined through systematic review and meta-analysis. Addiction 2009 1.60
14 Comparative quantification of alcohol exposure as risk factor for global burden of disease. Int J Methods Psychiatr Res 2007 1.58
15 Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction 2006 1.45
16 The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs 2007 1.30
17 Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology. Int J Methods Psychiatr Res 2006 1.21
18 Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005. BMC Public Health 2012 1.15
19 Social cost of heavy drinking and alcohol dependence in high-income countries. Int J Public Health 2009 1.14
20 Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users. Drug Alcohol Rev 2008 1.05
21 Determination of lifetime injury mortality risk in Canada in 2002 by drinking amount per occasion and number of occasions. Am J Epidemiol 2008 1.01
22 Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis. Int J Cancer 2007 1.01
23 Alcohol-attributable burden of disease and injury in Canada, 2004. Int J Public Health 2011 1.00
24 How many people in Canada use prescription opioids non-medically in general and street drug using populations? Can J Public Health 2009 0.99
25 Estimating chronic disease deaths and hospitalizations due to alcohol use in Canada in 2002: implications for policy and prevention strategies. Prev Chronic Dis 2006 0.98
26 Smoking-attributable mortality and expected years of life lost in Canada 2002: conclusions for prevention and policy. Chronic Dis Can 2007 0.97
27 Global burden of injuries attributable to alcohol consumption in 2004: a novel way of calculating the burden of injuries attributable to alcohol consumption. Popul Health Metr 2012 0.93
28 Alcohol-attributable morbidity and resulting health care costs in Canada in 2002: recommendations for policy and prevention. J Stud Alcohol Drugs 2007 0.91
29 Alcohol consumption and alcohol-attributable burden of disease in Switzerland, 2002. Int J Public Health 2007 0.89
30 Different guidelines for different countries? On the scientific basis of low-risk drinking guidelines and their implications. Drug Alcohol Rev 2011 0.87
31 Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN). J Subst Abuse Treat 2007 0.87
32 Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey. Int J Methods Psychiatr Res 2010 0.86
33 Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy 2007 0.86
34 Smoking-attributable morbidity: acute care hospital diagnoses and days of treatment in Canada, 2002. BMC Public Health 2007 0.86
35 Illegal drug-attributable morbidity in Canada 2002. Drug Alcohol Rev 2007 0.85
36 Prevalence and associated factors of hepatitis C infection (HCV) in a multi-site Canadian population of illicit opioid and other drug users (OPICAN). Can J Public Health 2007 0.83
37 Avoidable portion of tobacco-attributable acute care hospital days and its cost due to implementation of different intervention strategies in Canada. Int J Environ Res Public Health 2009 0.81
38 Avoidable cost of alcohol abuse in Canada. Eur Addict Res 2010 0.79
39 A literature review of cost-benefit analyses for the treatment of alcohol dependence. Int J Environ Res Public Health 2011 0.79
40 Cost of privatisation versus government alcohol retailing systems: Canadian example. Drug Alcohol Rev 2012 0.78
41 Strategies for evaluating the economic value of drugs in alcohol dependence treatment. Drug Alcohol Depend 2011 0.77
42 The disease burden of alcohol consumption. CMAJ 2007 0.75
43 Association of STOP-Bang Questionnaire as a Screening Tool for Sleep Apnea and Postoperative Complications: A Systematic Review and Bayesian Meta-analysis of Prospective and Retrospective Cohort Studies. Anesth Analg 2017 0.75
44 Postoperative Outcomes in Obstructive Sleep Apnea Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis of Comparative Studies. Anesth Analg 2017 0.75